搜索
阿斯利康
AZN添加自选
195.150USD
+11.280+6.14%
收盘 07/02, 16:00（美东）报价延迟15分钟
299.35B总市值
29.11市盈率 TTM
关于 阿斯利康 公司
阿斯特捷利康是一家科研驱动的全球生物制药企业，致力于将科学突破快速转化为患者可及的治疗选项，专注肿瘤、罕见疾病以及心血管、肾脏代谢、呼吸与免疫等领域的处方创新，并拓展疫苗与免疫疗法。公司核心肿瘤药物组合涵盖 Tagrisso、Imfinzi、Lynparza、Calquence、Enhertu、Orpathys、Zoladex、Faslodex 等；罕见病线持续拥有 Soliris、Ultomiris、Strensiq、Kanuma；生物制药线提供 Farxiga、Crestor、Breztri 等多款产品。当前研发管线中，候选疫苗 IVX-A12 用于应对呼吸道合胞病毒与人类偏肺病毒，肿瘤候选药 FPI-2265 靶向转移性去势抵抗性前列腺癌，并正开展 II 期临床研究。公司同时积极投入 T 细胞受体疗法与治疗肽 Eneboparatide 的开发工作。
阿斯利康简介
公司代码AZN
公司名称AstraZeneca PLC
上市日期Sep 21, 2007
CEODunoyer (Marc)
员工数量94300
证券类型Ordinary Share
年结日Sep 21
公司地址1 Francis Crick Avenue
城市CAMBRIDGE
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United Kingdom
邮编CB2 0AA
电话442073045000
网址https://www.astrazeneca.com/
公司代码AZN
上市日期Sep 21, 2007
CEODunoyer (Marc)
阿斯利康公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Pascal Soriot
Mr. Pascal Soriot
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
370.43K
+4.96%
Mr. Marcus Wallenberg
Mr. Marcus Wallenberg
Non-Executive Director
Non-Executive Director
60.03K
--
Mr. Michel Demare
Mr. Michel Demare
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
10.00K
--
Mr. Philip Broadley
Mr. Philip Broadley
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
8.03K
--
Dr. Euan Ashley
Dr. Euan Ashley
Non-Executive Independent Director
Non-Executive Independent Director
1.54K
--
Ms. Diana Layfield
Ms. Diana Layfield
Non-Executive Independent Director
Non-Executive Independent Director
1.40K
--
Ms. Nazneen Rahman
Ms. Nazneen Rahman
Non-Executive Independent Director
Non-Executive Independent Director
720.00
-41.25%
Ms. Anna Manz
Ms. Anna Manz
Non-Executive Independent Director
Non-Executive Independent Director
487.00
--
Ms. Pam P. Cheng
Ms. Pam P. Cheng
Executive Vice President - Global Operations, Information Technology and Chief Sustainability Officer
Executive Vice President - Global Operations, Information Technology and Chief Sustainability Officer
--
--
Ms. Sherilyn S. (Sheri) Mccoy
Ms. Sherilyn S. (Sheri) Mccoy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Pascal Soriot
Mr. Pascal Soriot
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
370.43K
+4.96%
Mr. Marcus Wallenberg
Mr. Marcus Wallenberg
Non-Executive Director
Non-Executive Director
60.03K
--
Mr. Michel Demare
Mr. Michel Demare
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
10.00K
--
Mr. Philip Broadley
Mr. Philip Broadley
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
8.03K
--
Dr. Euan Ashley
Dr. Euan Ashley
Non-Executive Independent Director
Non-Executive Independent Director
1.54K
--
Ms. Diana Layfield
Ms. Diana Layfield
Non-Executive Independent Director
Non-Executive Independent Director
1.40K
--
常见问题
阿斯利康的前五大股东是谁？
阿斯利康 的前五大股东如下：Mr. Pascal Soriot
有多少机构持有阿斯利康(AZN)的股份？
截至2026Q1，共有1863家机构持有阿斯利康的股份，合计持有的股份价值约为1.03B，占公司总股份的66.44%。与2025Q4相比，机构持股有所增加，增幅为156231135.00。
哪个业务部门对阿斯利康的收入贡献最大？
在2026Q1，Farxiga业务部门对阿斯利康的收入贡献最大，创收8.40B，占总收入的15.12%。